Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Breast Cancer

Free Subscription 24.05.2021 5 Ann Surg Oncol 7 BMC Cancer 4 Br J Cancer 5 Breast Cancer 1 Breast Cancer (Auckl) 3 Breast Cancer (Dove Med Press) 1 Breast Cancer Res 2 Breast Cancer Res Treat 1 Breast J 1 Cancer 3 Cancer Res 1 Carcinogenesis 4 Clin Breast Cancer 1 Clin Cancer Res 1 Eur J Cancer 4 Eur Radiol 2 Int J Cancer 2 J Clin Oncol 2 J Natl Cancer Inst 1 J Nucl Med 1 JAMA 2 Lancet Oncol 3 NPJ Breast Cancer 1 Oncogene 1 Oncol Rep 2 PLoS One 2 Proc Natl Acad Sci U S A 2 Radiology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Surg Oncol

1. CAO L, Hue JJ, Freyvogel M, Li P, et al
   Despite Equivalent Outcomes, Men Receive Neoadjuvant Chemotherapy Less Often Than Women for Lymph Node-Positive Breast Cancer.
   Ann Surg Oncol. 2021 May 16. pii: 10.1245/s10434-021-09994.
   PubMed        
   
   
2. DA COSTA VIEIRA RA, de Oliveira-Junior I, Branquinho LI, Haikel RL, et al
   Modified External Oblique Myocutaneous Flap for Repair of Postmastectomy Defects in Locally Advanced Breast Tumors: A Cohort Series Associated with a Systematic Review of Literature.
   Ann Surg Oncol. 2021;28:3356-3364.
   PubMed         Abstract available
   
   
3. MILLER ME, Patil N, Li P, Freyvogel M, et al
   Hospital System Adoption of Magnetic Seeds for Wireless Breast and Lymph Node Localization.
   Ann Surg Oncol. 2021;28:3223-3229.
   PubMed         Abstract available
   
   
4. WEISS A, Campbell J, Ballman KV, Sikov WM, et al
   ASO Visual Abstract: Factors Associated with Nodal Pathologic Complete Response Among Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: Results of CALGB 40601 (HER2+) and 40603 (Triple-Negative) (Alliance).
   Ann Surg Oncol. 2021 May 15. pii: 10.1245/s10434-021-10005.
   PubMed        
   
   
5. SATYANANDA V, Oshi M, Endo I, Takabe K, et al
   ASO Visual Abstract: High BRCA2 Gene Expression is Associated with Aggressive and Highly Proliferative Breast Cancer.
   Ann Surg Oncol. 2021 May 19. pii: 10.1245/s10434-021-10098.
   PubMed        
   
   

   
   BMC Cancer

6. NITTALA MR, Mundra EK, Packianathan S, Mehta D, et al
   The Will Rogers phenomenon, breast cancer and race.
   BMC Cancer. 2021;21:554.
   PubMed         Abstract available
   
   
7. MILLS MN, Naz A, Thawani C, Walker C, et al
   Capecitabine and stereotactic radiation in the management of breast cancer brain metastases.
   BMC Cancer. 2021;21:552.
   PubMed         Abstract available
   
   
8. ZHANG M, Wang B, Liu N, Wang H, et al
   Nomogram for predicting preoperative regional lymph nodes metastasis in patients with metaplastic breast cancer: a SEER population-based study.
   BMC Cancer. 2021;21:565.
   PubMed         Abstract available
   
   
9. AREFAN D, Hausler RM, Sumkin JH, Sun M, et al
   Predicting cell invasion in breast tumor microenvironment from radiological imaging phenotypes.
   BMC Cancer. 2021;21:370.
   PubMed         Abstract available
   
   
10. CHAN CWH, Law BMH, Ng MSN, Wong CCY, et al
    Association of single nucleotide polymorphisms of cytochrome P450 enzymes with experience of vasomotor, vaginal and musculoskeletal symptoms among breast cancer patients: a systematic review.
    BMC Cancer. 2021;21:570.
    PubMed         Abstract available
    
    
11. ZHANG Y, Asad S, Weber Z, Tallman D, et al
    Genomic features of rapid versus late relapse in triple negative breast cancer.
    BMC Cancer. 2021;21:568.
    PubMed         Abstract available
    
    
12. ZOGRAFOS E, Korakiti AM, Andrikopoulou A, Rellias I, et al
    Germline mutations in a clinic-based series of pregnancy associated breast cancer patients.
    BMC Cancer. 2021;21:572.
    PubMed         Abstract available
    
    

    
    Br J Cancer

13. PAN K, Aragaki AK, Neuhouser ML, Simon MS, et al
    Low-fat dietary pattern and breast cancer mortality by metabolic syndrome components: a secondary analysis of the Women's Health Initiative (WHI) randomised trial.
    Br J Cancer. 2021 May 18. pii: 10.1038/s41416-021-01379.
    PubMed         Abstract available
    
    
14. FARVID MS, Barnett JB, Spence ND
    Fruit and vegetable consumption and incident breast cancer: a systematic review and meta-analysis of prospective studies.
    Br J Cancer. 2021 May 18. pii: 10.1038/s41416-021-01373.
    PubMed         Abstract available
    
    
15. OKINES AFC, Kipps E, Irfan T, Coakley M, et al
    Impact of timing of adjuvant chemothapy for early breast cancer: the Royal Marsden Hospital experience.
    Br J Cancer. 2021 May 20. pii: 10.1038/s41416-021-01428.
    PubMed         Abstract available
    
    
16. ENGVALL K, Green H, Fredriksson M, Avall-Lundqvist E, et al
    Persistent neuropathy among early-stage breast cancer survivors in a population-based cohort.
    Br J Cancer. 2021 May 20. pii: 10.1038/s41416-021-01429.
    PubMed         Abstract available
    
    

    
    Breast Cancer

17. IWATA H, Saji S, Ikeda M, Inokuchi M, et al
    Correction to: The Japanese Breast Cancer Society Clinical Practice Guidelines, 2018 edition: the tool for shared decision making between doctor and patient.
    Breast Cancer. 2021 May 19. pii: 10.1007/s12282-021-01253.
    PubMed        
    
    
18. WANG L, Li Q, Aushev VN, Neugut AI, et al
    PAM50- and immunohistochemistry-based subtypes of breast cancer and their relationship with breast cancer mortality in a population-based study.
    Breast Cancer. 2021 May 18. pii: 10.1007/s12282-021-01261.
    PubMed         Abstract available
    
    
19. YAMAUCHI C, Yoshimura M, Sekiguchi K, Hamamoto Y, et al
    Correction to: The Japanese Breast Cancer Society Clinical Practice Guideline for radiation treatment of breast cancer, 2018 edition.
    Breast Cancer. 2021 May 19. pii: 10.1007/s12282-021-01255.
    PubMed        
    
    
20. INOKUCHI M, Kutomi G, Kijima Y, Sakai T, et al
    Correction to: The Japanese Breast Cancer Society clinical practice guidelines for surgical treatment of breast cancer, 2018 edition.
    Breast Cancer. 2021 May 19. pii: 10.1007/s12282-021-01256.
    PubMed        
    
    
21. UEMATSU T, Nakashima K, Kikuchi M, Kubota K, et al
    Correction to: The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer Screening and Diagnosis, 2018 Edition.
    Breast Cancer. 2021 May 19. pii: 10.1007/s12282-021-01251.
    PubMed        
    
    

    
    Breast Cancer (Auckl)

22. SCHICK J, Ritchie RP, Restini C
    Breast Cancer Therapeutics and Biomarkers: Past, Present, and Future Approaches.
    Breast Cancer (Auckl). 2021;15:1178223421995854.
    PubMed         Abstract available
    
    

    
    Breast Cancer (Dove Med Press)

23. TSEGAYE S, Mehdi M, Labisso WL, Melka DS, et al
    Cysteine Cathepsins and Matrix Metalloproteases Among Breast Cancer Patients.
    Breast Cancer (Dove Med Press). 2021;13:271-283.
    PubMed         Abstract available
    
    
24. YOUNIS M, Norsa'adah B, Othman A
    Effectiveness of Psycho-Education Intervention Programme on Coping Strategies Among Jordanian Women Diagnosed with Breast Cancer: A Randomised Controlled Trial.
    Breast Cancer (Dove Med Press). 2021;13:285-297.
    PubMed         Abstract available
    
    
25. LAZZARI G, Buono G, Zannino B, Silvano G, et al
    Breast Cancer Adjuvant Radiotherapy in BRCA1/2, TP53, ATM Genes Mutations: Are There Solved Issues?
    Breast Cancer (Dove Med Press). 2021;13:299-310.
    PubMed         Abstract available
    
    

    
    Breast Cancer Res

26. DINCA SC, Greiner D, Weidenfeld K, Bond L, et al
    Novel mechanism for OSM-promoted extracellular matrix remodeling in breast cancer: LOXL2 upregulation and subsequent ECM alignment.
    Breast Cancer Res. 2021;23:56.
    PubMed         Abstract available
    
    

    
    Breast Cancer Res Treat

27. DELRIEU L, Martin A, Touillaud M, Perol O, et al
    Sarcopenia and serum biomarkers of oxidative stress after a 6-month physical activity intervention in women with metastatic breast cancer: results from the ABLE feasibility trial.
    Breast Cancer Res Treat. 2021 May 19. pii: 10.1007/s10549-021-06238.
    PubMed         Abstract available
    
    
28. ZHOU Y, Xu Y, Wang C, Gong Y, et al
    Serial circulating tumor DNA identification associated with the efficacy and prognosis of neoadjuvant chemotherapy in breast cancer.
    Breast Cancer Res Treat. 2021 May 18. pii: 10.1007/s10549-021-06247.
    PubMed         Abstract available
    
    

    
    Breast J

29. WANG L, Asirvatham JR, Ma Y, Reisenbichler ES, et al
    HER-2/neu-positive breast cancer neoadjuvant chemotherapy response after implementation of 2018 ASCO/CAP focused update.
    Breast J. 2021 May 20. doi: 10.1111/tbj.14241.
    PubMed         Abstract available
    
    

    
    Cancer

30. SUNG H, Freedman RA, Siegel RL, Hyun N, et al
    Risks of subsequent primary cancers among breast cancer survivors according to hormone receptor status.
    Cancer. 2021 May 18. doi: 10.1002/cncr.33602.
    PubMed         Abstract available
    
    

    
    Cancer Res

31. KUMARASAMY V, Vail P, Nambiar R, Witkiewicz AK, et al
    Functional Determinants of Cell Cycle Plasticity and Sensitivity to CDK4/6 Inhibition.
    Cancer Res. 2021;81:1347-1360.
    PubMed         Abstract available
    
    
32. DAI M, Boudreault J, Wang N, Poulet S, et al
    Differential Regulation of Cancer Progression by CDK4/6 Plays a Central Role in DNA Replication and Repair Pathways.
    Cancer Res. 2021;81:1332-1346.
    PubMed         Abstract available
    
    
33. SHARMA D
    Towards Taming the Bugs to Improve the Drugs for Breast Cancer.
    Cancer Res. 2021;81:1937-1939.
    PubMed         Abstract available
    
    

    
    Carcinogenesis

34. COOGAN PF, Rosenberg L, Palmer JR, Cozier YC, et al
    Hair product use and breast cancer incidence in the Black Women's Health Study.
    Carcinogenesis. 2021 May 20. pii: 6278856. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Clin Breast Cancer

35. PANG J, Zhou H, Dong X, Wang S, et al
    Relationship Between the Neutrophil to Lymphocyte Ratio, Stromal Tumor-infiltrating Lymphocytes, and the Prognosis and Response to Neoadjuvant Chemotherapy in Triple-negative Breast Cancer.
    Clin Breast Cancer. 2021 Apr 14. pii: S1526-8209(21)00072.
    PubMed         Abstract available
    
    
36. LI X, Yan C, Xiao J, Xu X, et al
    Factors Associated With Surgical Modality Following Neoadjuvant Chemotherapy in Patients with Breast Cancer.
    Clin Breast Cancer. 2021 Apr 8. pii: S1526-8209(21)00066.
    PubMed         Abstract available
    
    
37. LEE E, Tweed C, Mylander C, Martino L, et al
    The Impact of Genomic Profiling on Adjuvant Therapy Recommendation in Postmenopausal Women with ER-Positive, T1-2 Breast Cancer: Can Genomic Profiling Eliminate the Need for Sentinel Lymph Node Biopsy?
    Clin Breast Cancer. 2021 Mar 4. pii: S1526-8209(21)00053.
    PubMed         Abstract available
    
    
38. WERUTSKY G, Reinert T, Rosa ML, Barrios CH, et al
    Real-world Data on First-line Systemic Therapy for Hormone Receptor-positive HER2-negative Metastatic Breast Cancer: A Trend Shift in the Era of CDK 4/6 Inhibitors.
    Clin Breast Cancer. 2021 Apr 20. pii: S1526-8209(21)00071.
    PubMed         Abstract available
    
    

    
    Clin Cancer Res

39. SERVETTO A, Kollipara R, Formisano L, Lin CC, et al
    Nuclear FGFR1 regulates gene transcription and promotes antiestrogen resistance in ER+ breast cancer.
    Clin Cancer Res. 2021 May 19. pii: 1078-0432.CCR-20-3905.
    PubMed         Abstract available
    
    

    
    Eur J Cancer

40. KIM HJ, Noh WC, Nam SJ, Park BW, et al
    Five-year changes in ovarian function restoration in premenopausal patients with breast cancer taking tamoxifen after chemotherapy: An ASTRRA study report.
    Eur J Cancer. 2021;151:190-200.
    PubMed         Abstract available
    
    

    
    Eur Radiol

41. SCHAFGEN B, Juskic M, Radicke M, Hertel M, et al
    Evaluation of the FUSION-X-US-II prototype to combine automated breast ultrasound and tomosynthesis.
    Eur Radiol. 2021;31:3712-3720.
    PubMed         Abstract available
    
    
42. MARTIN E, Boudier J, Salleron J, Henrot P, et al
    Synchronous BI-RADS category 3 lesions detected by preoperative breast MRI in patients with breast cancer: may follow-up be adequate?
    Eur Radiol. 2021 May 15. pii: 10.1007/s00330-021-07983.
    PubMed         Abstract available
    
    
43. BUUS TW, Rasmussen F, Nellemann HM, Logager V, et al
    Comparison of contrast-enhanced CT, dual-layer detector spectral CT, and whole-body MRI in suspected metastatic breast cancer: a prospective diagnostic accuracy study.
    Eur Radiol. 2021 May 18. pii: 10.1007/s00330-021-08041.
    PubMed         Abstract available
    
    
44. COHEN EO, Perry RE, Tso HH, Phalak KA, et al
    Breast cancer screening in women with and without implants: retrospective study comparing digital mammography to digital mammography combined with digital breast tomosynthesis.
    Eur Radiol. 2021 May 20. pii: 10.1007/s00330-021-08040.
    PubMed         Abstract available
    
    

    
    Int J Cancer

45. WU AH, Franke AA, Wilkens LR, Tseng C, et al
    Risk of Breast Cancer and pre-diagnostic urinary excretion of bisphenol A, triclosan, and parabens: the Multiethnic Cohort Study.
    Int J Cancer. 2021 May 20. doi: 10.1002/ijc.33692.
    PubMed         Abstract available
    
    
46. ALSENDI M, O'Reilly D, Zeidan YH, Kelly CM, et al
    Oligometastatic Breast Cancer: Are We There Yet?
    Int J Cancer. 2021 May 20. doi: 10.1002/ijc.33693.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

47. TOLANEY SM, Garrett-Mayer E, White J, Blinder VS, et al
    Updated Standardized Definitions for Efficacy End Points (STEEP) in Adjuvant Breast Cancer Clinical Trials: STEEP Version 2.0.
    J Clin Oncol. 2021 May 18:JCO2003613. doi: 10.1200/JCO.20.03613.
    PubMed         Abstract available
    
    
48. CONNOLLY RM, Leal JP, Solnes L, Huang CY, et al
    Updated Results of TBCRC026: Phase II Trial Correlating Standardized Uptake Value With Pathological Complete Response to Pertuzumab and Trastuzumab in Breast Cancer.
    J Clin Oncol. 2021 May 17:JCO2100280. doi: 10.1200/JCO.21.00280.
    PubMed         Abstract available
    
    

    
    J Natl Cancer Inst

49. ZHANG J, Yang M
    RE: Assessment of Ki67 in Breast Cancer: Updated Recommendations from the International Ki67 in Breast Cancer Working Group.
    J Natl Cancer Inst. 2021 May 18. pii: 6277733. doi: 10.1093.
    PubMed        
    
    
50. KANTOR O, King TA, Shak S, Russell CA, et al
    Expanding Criteria for Prognostic Stage IA in Hormone Receptor-Positive Breast Cancer.
    J Natl Cancer Inst. 2021 May 19. pii: 6278359. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Nucl Med

51. MORAWITZ J, Bruckmann NM, Dietzel F, Ullrich T, et al
    Determining the axillary nodal status with four current imaging modalities including (18)F-FDG PET/MRI in newly diagnosed breast cancer: A comparative study using histopathology as reference standard.
    J Nucl Med. 2021 May 20. pii: jnumed.121.262009. doi: 10.2967/jnumed.121.262009.
    PubMed         Abstract available
    
    

    
    JAMA

52. JATOI I, Kemp Z
    Risk-Reducing Mastectomy.
    JAMA. 2021;325:1781-1782.
    PubMed        
    
    

    
    Lancet Oncol

53. BIGANZOLI L, Battisti NML, Wildiers H, McCartney A, et al
    Updated recommendations regarding the management of older patients with breast cancer: a joint paper from the European Society of Breast Cancer Specialists (EUSOMA) and the International Society of Geriatric Oncology (SIOG).
    Lancet Oncol. 2021 May 14. pii: S1470-2045(20)30741.
    PubMed         Abstract available
    
    
54. PEREZ-GARCIA JM, Gebhart G, Ruiz Borrego M, Stradella A, et al
    Chemotherapy de-escalation using an (18)F-FDG-PET-based pathological response-adapted strategy in patients with HER2-positive early breast cancer (PHERGain): a multicentre, randomised, open-label, non-comparative, phase 2 trial.
    Lancet Oncol. 2021 May 18. pii: S1470-2045(21)00122.
    PubMed         Abstract available
    
    

    
    NPJ Breast Cancer

55. ZELEZNIK OA, Balasubramanian R, Zhao Y, Frueh L, et al
    Circulating amino acids and amino acid-related metabolites and risk of breast cancer among predominantly premenopausal women.
    NPJ Breast Cancer. 2021;7:54.
    PubMed         Abstract available
    
    
56. SCHLAM I, Swain SM
    HER2-positive breast cancer and tyrosine kinase inhibitors: the time is now.
    NPJ Breast Cancer. 2021;7:56.
    PubMed         Abstract available
    
    
57. VAHDAT LT, Schmid P, Forero-Torres A, Blackwell K, et al
    Glembatumumab vedotin for patients with metastatic, gpNMB overexpressing, triple-negative breast cancer ("METRIC"): a randomized multicenter study.
    NPJ Breast Cancer. 2021;7:57.
    PubMed         Abstract available
    
    

    
    Oncogene

58. LODILLINSKY C, Fuhrmann L, Irondelle M, Pylypenko O, et al
    Metastasis-suppressor NME1 controls the invasive switch of breast cancer by regulating MT1-MMP surface clearance.
    Oncogene. 2021 May 19. pii: 10.1038/s41388-021-01826.
    PubMed         Abstract available
    
    

    
    Oncol Rep

59. TANAKA T, Ohishi T, Asano T, Takei J, et al
    An antiTROP2 monoclonal antibody TrMab6 exerts antitumor activity in breast cancer mouse xenograft models.
    Oncol Rep. 2021;46.
    PubMed         Abstract available
    
    

    
    PLoS One

60. LEE SB, Kim H, Kim J, Chung IY, et al
    Prognosis according to clinical and pathologic lymph node status in breast cancer patients who underwent sentinel lymph node biopsy alone after neoadjuvant therapy.
    PLoS One. 2021;16:e0251597.
    PubMed         Abstract available
    
    
61. MA S, Shepard DS, Ritter GA, Martell RE, et al
    Cost sharing for breast cancer hormone therapy: How do dual eligible patients' copayment impact adherence.
    PLoS One. 2021;16:e0250967.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

62. PRADHAN AK, Maji S, Bhoopathi P, Talukdar S, et al
    Pharmacological inhibition of MDA-9/Syntenin blocks breast cancer metastasis through suppression of IL-1beta.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available
    
    
63. DING Y, Liu Y, Lee DK, Tong Z, et al
    Cell lineage tracing links ERalpha loss in Erbb2-positive breast cancers to the arising of a highly aggressive breast cancer subtype.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available
    
    

    
    Radiology

64. MOY L, Gao Y
    Digital Mammography Is Similar to Screen-Film Mammography for Women with Personal History of Breast Cancer.
    Radiology. 2021 May 18:210930. doi: 10.1148/radiol.2021210930.
    PubMed        
    
    
65. LEE JM, Ichikawa LE, Wernli KJ, Bowles E, et al
    Digital Mammography and Breast Tomosynthesis Performance in Women with a Personal History of Breast Cancer, 2007-2016.
    Radiology. 2021 May 18:204581. doi: 10.1148/radiol.2021204581.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: